XILIS, Inc.
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective treatments for patients, but existing approaches only benefit a minority of patients. Xilis is developing next generation MicroOrganoSphere technologies to guide precision therapy for cancer patients and accelerate drug discovery.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
About Us
Informed Choices. Better Outcomes.
Developed by world-class scientists from the U.S. and Europe, Xilis’ MicroOrganoSphere (MOS) technology and Precision Oncology Platform is transforming treatment choices in the clinic and bringing novel therapeutics to patients.
Technology
Xilis is developing next-generation technologies to guide precision therapy for cancer patients and accelerate drug discovery and development. MOS are microscale tumors that retain structure, genetic alterations, gene expression, immune microenvironment, and histopathology from individual patients. Our MOS platform enables rapid diagnostics for personalized therapy prioritization by predicting patient response, and scalable patient-derived models for high-throughput and immuno-oncology drug discovery.
Our Story
Xilis is developing next generation technologies that provide a functional model of a patient’s individual tumor that can be directly tested for drug response, helping clinicians make timely treatment decisions for cancer patients and supporting drug development for world-leading pharmaceutical partners. The company’s MicroOrganoSphereTM (MOS) technology and Precision Oncology Platform allows for rapid diagnostics, personalized patient care, and scalable patient-derived models for high-throughput drug discovery.
Xilis was founded in 2019 when the three founders -- an engineer, a physician and a biologist -- decided to develop and commercialize their technology to transform cancer care. As leaders in their respective fields and their unique experiences from bench to bedside, they have been working closely with clinicians and partnering with pharmaceutical companies to bring the right drugs to the right patients.
Our Values
Our Vision Statement & Mission Statement
Our Vision
The engine of a precision-medicine based healthcare system where effective therapies can be selected for every patient by leveraging scalable, comprehensive, and predictive patient-derived models of disease.
Our Mission
Our predictive and scalable MicroOrganoSphere platform, consisting of accurate biological models and measurements, robotic systems, and AI will be used to 1) provide diagnostics assays that guide cancer patients to the most effective approved treatment, 2) accelerate the development of novel and effective individualized options available to patients, and 3) contribute significantly to improve patient outcomes.
Our Culture
Mission Focused.
Build for everyone, with everyone.
At Xilis, we have an unwavering commitment to use our technology, skills, and time to provide patients with transformative new diagnostics and therapeutics. The Xilis team is mission driven by keeping patients and products in mind when making decisions, building for everyone, and connecting with our community.
Data-driven Decision Making
Integrity breeds integrity, trust breeds trust.
At Xilis, we strive to become a trusted component of our healthcare industry. Our actions, decisions, and behaviors have an impact on the quality of the work we do, the value of our products to patients, and ultimately on the impact we have on the community. Data, and the integrity that stems from it, needs to guide our every action so we can precisely assess any given situation and make decisions that will most benefit patients.
Servant Leadership
Cross-functional support and leadership.
Xilis is first and foremost at the service of patients and dedicated to bringing novel and life saving diagnostic assays and drug treatments to patients. We firmly believe the legitimacy of authority in managerial relationships comes from empowering and enabling the right people to perform the most important and valuable tasks and make the right decisions. The leadership and management of Xilis are singularly dedicated to our team's success by committing to serve and build trust within our organization and with our partners.